Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Target-volume and critical-organ delineation for conformal radiotherapy of prostate cancer: experience of French dose-escalation trials].
Beckendorf V, Bachaud JM, Bey P, Bourdin S, Carrie C, Chapet O, Cowen D, Guérif S, Hay HM, Lagrange JL, Maingon P, Le Prisé E, Pommier P, Simon JM. Beckendorf V, et al. Among authors: bourdin s. Cancer Radiother. 2002 Nov;6 Suppl 1:78s-92s. doi: 10.1016/s1278-3218(02)00217-2. Cancer Radiother. 2002. PMID: 12587386 Review. French.
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity.
Beckendorf V, Guérif S, Le Prisé E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, Hay MH, Dubray B, Luporsi E, Bey P. Beckendorf V, et al. Among authors: bourdin s. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1056-65. doi: 10.1016/j.ijrobp.2004.05.033. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519775 Clinical Trial.
Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study.
Bensadoun RJ, Etienne MC, Dassonville O, Chauvel P, Pivot X, Marcy PY, Prevost B, Coche-Dequeant B, Bourdin S, Vallicioni J, Poissonnet G, Courdi A, Teissier E, Lagrange JL, Thyss A, Santini J, Demard F, Schneider M, Milano G. Bensadoun RJ, et al. Among authors: bourdin s. Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):237-45. doi: 10.1016/s0360-3016(98)00235-1. Int J Radiat Oncol Biol Phys. 1998. PMID: 9788400 Clinical Trial.
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma].
Mornex F, Thomas L, Mohr P, Hauschild A, Delaunay MM, Lesimple T, Tilgen W, Nguyen BB, Guillot B, Ulrich J, Bourdin S, Mousseau M, Cupissol D, Bonneterre J, de Gislain C, Bensadoun JR, Clavel M. Mornex F, et al. Among authors: bourdin s. Cancer Radiother. 2003 Feb;7(1):1-8. doi: 10.1016/s1278-3218(02)00284-6. Cancer Radiother. 2003. PMID: 12648711 Clinical Trial. French.
No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
Marchand V, Bourdin S, Charbonnel C, Rio E, Munos C, Campion L, Bonnaud-Antignac A, Lisbona A, Mahé MA, Supiot S. Marchand V, et al. Among authors: bourdin s. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1053-9. doi: 10.1016/j.ijrobp.2009.06.024. Epub 2009 Oct 31. Int J Radiat Oncol Biol Phys. 2010. PMID: 19880259
[Radiosurgery for brain arteriovenous malformations].
Latorzeff I, Schlienger M, Sabatier J, Borius PY, Bourdin S, Menegalli D, Cognard C, Januel AC, Lotterie JA, Desal H, Debono B, Blond S. Latorzeff I, et al. Among authors: bourdin s. Cancer Radiother. 2012 Jun;16 Suppl:S46-56. doi: 10.1016/j.canrad.2012.05.003. Epub 2012 Jun 20. Cancer Radiother. 2012. PMID: 22721755 Review. French.
37 results